View Future GrowthThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsNova Cannabis 過去の業績過去 基準チェック /26Nova Cannabisは、平均年間25.6%の収益成長を遂げていますが、 Specialty Retail業界の収益は、年間 減少しています。収益は、平均年間3.1% 30.4%収益成長率で 成長しています。 Nova Cannabisの自己資本利益率は5.3%であり、純利益率は1.1%です。主要情報25.64%収益成長率49.40%EPS成長率Specialty Retail 業界の成長26.64%収益成長率30.39%株主資本利益率5.31%ネット・マージン1.14%前回の決算情報30 Jun 2024最近の業績更新お知らせ • Jul 20Nova Cannabis Inc. to Report Q2, 2024 Results on Aug 01, 2024Nova Cannabis Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024お知らせ • May 01Nova Cannabis Inc. to Report Q1, 2024 Results on May 07, 2024Nova Cannabis Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024お知らせ • Mar 13Nova Cannabis Inc. to Report Q4, 2023 Results on Mar 25, 2024Nova Cannabis Inc. announced that they will report Q4, 2023 results After-Market on Mar 25, 2024お知らせ • Nov 01Nova Cannabis Inc. to Report Q3, 2023 Results on Nov 08, 2023Nova Cannabis Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023お知らせ • Aug 04Nova Cannabis Inc. to Report Q2, 2023 Results on Aug 09, 2023Nova Cannabis Inc. announced that they will report Q2, 2023 results After-Market on Aug 09, 2023お知らせ • May 05Nova Cannabis Inc. to Report Q1, 2023 Results on May 10, 2023Nova Cannabis Inc. announced that they will report Q1, 2023 results After-Market on May 10, 2023すべての更新を表示Recent updatesお知らせ • Oct 22SNDL Completes Privatization of Nova Cannabis and Nova Shares Expected to be Delisted from the Toronto Stock Exchange and the OTC MarketsSNDL Inc. (‘SNDL’) and Nova Cannabis Inc. (‘Nova’) announced the closing of the previously announced plan of arrangement (the ‘Arrangement’) pursuant to which SNDL has acquired all of the issued and outstanding common shares in the capital of Nova (‘Nova Shares’) not already owned by SNDL, representing approximately 34.8% of the Nova Shares. The Arrangement was approved by at least two-thirds of the holders of Nova Shares (‘Nova Shareholders’) and the majority of disinterested Nova Shareholders under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions at a special meeting of the Nova Shareholders on October 16, 2024. The Court of King's Bench of Alberta granted a final order approving the Arrangement on October 17, 2024. The Nova Shares are expected to be delisted from the TSX and the OTC Markets. Following the delisting of the Nova Shares, Nova intends to submit an application to cease to be a reporting issuer in each applicable jurisdiction of Canada pursuant to applicable securities laws, and, following which, SNDL intends to amalgamate with Nova pursuant to the provisions of the Business Corporations Act (Alberta). Registered holders of Nova Shares are reminded that they must send their completed and executed letter of transmittal and election form and related share certificates or DRS advices, if any, to the depository for the Arrangement, Odyssey Trust Company, as soon as possible in order to receive the Consideration to which they are entitled under the Arrangement.お知らせ • Aug 13Nova Shares to Be Delisted from the TSXSNDL Inc. ("SNDL") and Nova Cannabis Inc. ("Nova") announced that they have entered into an arrangement agreement (the "Agreement") pursuant to which SNDL will acquire all of the issued and outstanding common shares in the capital of Nova ("Nova Shares") not already owned by SNDL, representing approximately 34.8% of Nova Shares, by way of a statutory plan of arrangement (the "Transaction") for aggregate consideration of approximately $40 million (the "Consideration"). The Transaction has been approved by the boards of directors of both SNDL and Nova and is expected to close on or before October 18, 2024. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada.お知らせ • Jul 20Nova Cannabis Inc. to Report Q2, 2024 Results on Aug 01, 2024Nova Cannabis Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024お知らせ • Jul 16Nova Cannabis Inc. Announces Chief Executive Officer Changes, Effective August 1, 2024Nova Cannabis Inc. announced that Marcie Kiziak, Chief Executive Officer and a Director of Nova, will be stepping down from her role of Chief Executive Officer, effective August 1, 2024. Ms. Kiziak will continue to serve as a Director of Nova until second quarter 2024 financial results are announced. This decision comes in connection with the restructuring announced by SNDL Inc. earlier July 16, 2024. Ms. Kiziak successfully led Nova through the early years of Canadian federal legalization and worked to build a unique and highly disruptive discount strategy in Cannabis retail. Nova's success prompted a number of retail operators to follow suit, bringing greater value and convenience to consumers. Under her leadership, the Nova team has grown the Value Buds portfolio to more than 100 stores through a combination of organic and inorganic growth. Taking the reins as Interim Chief Executive Officer will be Grant Sanderson, Nova's current Chief Operating Officer. Sanderson's appointment will take effect upon Ms. Kiziak's departure.お知らせ • May 17Nova Cannabis Inc., Annual General Meeting, Jun 20, 2024Nova Cannabis Inc., Annual General Meeting, Jun 20, 2024.お知らせ • May 01Nova Cannabis Inc. to Report Q1, 2024 Results on May 07, 2024Nova Cannabis Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024お知らせ • Mar 13Nova Cannabis Inc. to Report Q4, 2023 Results on Mar 25, 2024Nova Cannabis Inc. announced that they will report Q4, 2023 results After-Market on Mar 25, 2024お知らせ • Nov 01Nova Cannabis Inc. to Report Q3, 2023 Results on Nov 08, 2023Nova Cannabis Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023お知らせ • Aug 04Nova Cannabis Inc. to Report Q2, 2023 Results on Aug 09, 2023Nova Cannabis Inc. announced that they will report Q2, 2023 results After-Market on Aug 09, 2023お知らせ • May 05Nova Cannabis Inc. to Report Q1, 2023 Results on May 10, 2023Nova Cannabis Inc. announced that they will report Q1, 2023 results After-Market on May 10, 2023収支内訳Nova Cannabis の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:NVAC.F 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費30 Jun 24269344031 Mar 24263341031 Dec 23259339030 Sep 23253-239030 Jun 23244-640031 Mar 23237-838031 Dec 22226-1136030 Sep 22213-1234030 Jun 22192-1631031 Mar 22166-2231031 Dec 21134-2127030 Sep 21104-1924030 Jun 2181-1120031 Mar 2166-416031 Dec 2063-215030 Sep 2059-314031 Dec 1941-912031 Dec 1810-11110質の高い収益: NVAC.FにはCA$3.2M } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が30th June, 2024に影響を及ぼしています。利益率の向上: NVAC.F過去に利益を上げました。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: NVAC.F過去 5 年間で収益を上げており、収益は年間25.6%増加しています。成長の加速: NVAC.Fは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。収益対業界: NVAC.F昨年収益を上げたため、昨年の収益成長をSpecialty Retail業界 ( -2.3% ) と比較することは困難です。株主資本利益率高いROE: NVAC.Fの 自己資本利益率 ( 5.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YRetail 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/10/21 04:01終値2024/10/21 00:00収益2024/06/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nova Cannabis Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Frederico Yokota Choucair GomesATB Cormark
お知らせ • Jul 20Nova Cannabis Inc. to Report Q2, 2024 Results on Aug 01, 2024Nova Cannabis Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024
お知らせ • May 01Nova Cannabis Inc. to Report Q1, 2024 Results on May 07, 2024Nova Cannabis Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024
お知らせ • Mar 13Nova Cannabis Inc. to Report Q4, 2023 Results on Mar 25, 2024Nova Cannabis Inc. announced that they will report Q4, 2023 results After-Market on Mar 25, 2024
お知らせ • Nov 01Nova Cannabis Inc. to Report Q3, 2023 Results on Nov 08, 2023Nova Cannabis Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023
お知らせ • Aug 04Nova Cannabis Inc. to Report Q2, 2023 Results on Aug 09, 2023Nova Cannabis Inc. announced that they will report Q2, 2023 results After-Market on Aug 09, 2023
お知らせ • May 05Nova Cannabis Inc. to Report Q1, 2023 Results on May 10, 2023Nova Cannabis Inc. announced that they will report Q1, 2023 results After-Market on May 10, 2023
お知らせ • Oct 22SNDL Completes Privatization of Nova Cannabis and Nova Shares Expected to be Delisted from the Toronto Stock Exchange and the OTC MarketsSNDL Inc. (‘SNDL’) and Nova Cannabis Inc. (‘Nova’) announced the closing of the previously announced plan of arrangement (the ‘Arrangement’) pursuant to which SNDL has acquired all of the issued and outstanding common shares in the capital of Nova (‘Nova Shares’) not already owned by SNDL, representing approximately 34.8% of the Nova Shares. The Arrangement was approved by at least two-thirds of the holders of Nova Shares (‘Nova Shareholders’) and the majority of disinterested Nova Shareholders under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions at a special meeting of the Nova Shareholders on October 16, 2024. The Court of King's Bench of Alberta granted a final order approving the Arrangement on October 17, 2024. The Nova Shares are expected to be delisted from the TSX and the OTC Markets. Following the delisting of the Nova Shares, Nova intends to submit an application to cease to be a reporting issuer in each applicable jurisdiction of Canada pursuant to applicable securities laws, and, following which, SNDL intends to amalgamate with Nova pursuant to the provisions of the Business Corporations Act (Alberta). Registered holders of Nova Shares are reminded that they must send their completed and executed letter of transmittal and election form and related share certificates or DRS advices, if any, to the depository for the Arrangement, Odyssey Trust Company, as soon as possible in order to receive the Consideration to which they are entitled under the Arrangement.
お知らせ • Aug 13Nova Shares to Be Delisted from the TSXSNDL Inc. ("SNDL") and Nova Cannabis Inc. ("Nova") announced that they have entered into an arrangement agreement (the "Agreement") pursuant to which SNDL will acquire all of the issued and outstanding common shares in the capital of Nova ("Nova Shares") not already owned by SNDL, representing approximately 34.8% of Nova Shares, by way of a statutory plan of arrangement (the "Transaction") for aggregate consideration of approximately $40 million (the "Consideration"). The Transaction has been approved by the boards of directors of both SNDL and Nova and is expected to close on or before October 18, 2024. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada.
お知らせ • Jul 20Nova Cannabis Inc. to Report Q2, 2024 Results on Aug 01, 2024Nova Cannabis Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024
お知らせ • Jul 16Nova Cannabis Inc. Announces Chief Executive Officer Changes, Effective August 1, 2024Nova Cannabis Inc. announced that Marcie Kiziak, Chief Executive Officer and a Director of Nova, will be stepping down from her role of Chief Executive Officer, effective August 1, 2024. Ms. Kiziak will continue to serve as a Director of Nova until second quarter 2024 financial results are announced. This decision comes in connection with the restructuring announced by SNDL Inc. earlier July 16, 2024. Ms. Kiziak successfully led Nova through the early years of Canadian federal legalization and worked to build a unique and highly disruptive discount strategy in Cannabis retail. Nova's success prompted a number of retail operators to follow suit, bringing greater value and convenience to consumers. Under her leadership, the Nova team has grown the Value Buds portfolio to more than 100 stores through a combination of organic and inorganic growth. Taking the reins as Interim Chief Executive Officer will be Grant Sanderson, Nova's current Chief Operating Officer. Sanderson's appointment will take effect upon Ms. Kiziak's departure.
お知らせ • May 17Nova Cannabis Inc., Annual General Meeting, Jun 20, 2024Nova Cannabis Inc., Annual General Meeting, Jun 20, 2024.
お知らせ • May 01Nova Cannabis Inc. to Report Q1, 2024 Results on May 07, 2024Nova Cannabis Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024
お知らせ • Mar 13Nova Cannabis Inc. to Report Q4, 2023 Results on Mar 25, 2024Nova Cannabis Inc. announced that they will report Q4, 2023 results After-Market on Mar 25, 2024
お知らせ • Nov 01Nova Cannabis Inc. to Report Q3, 2023 Results on Nov 08, 2023Nova Cannabis Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023
お知らせ • Aug 04Nova Cannabis Inc. to Report Q2, 2023 Results on Aug 09, 2023Nova Cannabis Inc. announced that they will report Q2, 2023 results After-Market on Aug 09, 2023
お知らせ • May 05Nova Cannabis Inc. to Report Q1, 2023 Results on May 10, 2023Nova Cannabis Inc. announced that they will report Q1, 2023 results After-Market on May 10, 2023